Congratulations to Drs Eric Chow and Tamsyn van Rheenen, Club Melbourne winners!

Dr Eric Chow (left) and Dr Tamsyn Van Rheenen (right) are
inaugural joint winners of the Club Melbourne Fellowship 

Congratulations to Dr Eric Chow (Melbourne Sexual Health Centre) and Dr Tamsyn Van Rheenen (formerly of Monash Alfred Psychiatry research centre, now at University of Melbourne) who won the Club Melbourne Fellowship Award on Monday 13 August.

In a first for the Program, the 2018 Club Melbourne Fellowship judging resulted in a unanimous tie, awarding Co-Fellows Dr Eric Chow and Dr Tamsyn Van Rheenen a $10,000 Fellowship each. The Fellowship is designed to support their attendance at international conferences to enable new, life changing opportunities for their research projects, with the hope that they will evolve to become Ambassadors themselves in the future.

Alfred HealthLink newsletter 2015 Autumn issue: TBI, Asthma, Anaesthesia, Bipolar & more

Alfred Health produces a regular newsletter, back issues of which are housed at: www.alfred.org.au/News.aspx?ID=469.

The current issue's highlights include:

• Asthma breakthrough (Prof Bruce Thompson, Department of Allergy, Immunology and Respiratory medicine)
• Monitoring healthy recovery after surgery (Dr Mark Shulman, Department of Anaesthesia and Perioperative Medicine)
• Brain imaging, bipolar and family (Dr Tamsyn van Rheenen, MAPrc)
• Global effort in brain injury research (Prof Jamie Cooper)

Enquiries to Public Affairs team at Alfred Health on 03 9076 2266 or publicaffairs@alfred.org.au

Let's face it: facial emotion processing is impaired in bipolar disorder.

Two researchers from MAPrc have published a study which looks at facial emotion processing in patients with bipolar disorder.

According to the study, patients with bipolar disorder have difficulty in recognizing and discriminating facial emotions.

Participants sought: Tibolone for menopausal depression

 Two new clinical trials aim to discover the best treatment approach for the understudied depression that affects a large proportion of women in their late forties and fifties prior to, during or post menopause. These trials compare the effectiveness of a hormone treatment (Tibolone) for women with depression related to menopause, and that of standard antidepressant medication. Interested persons should contact Tamsyn Van Rheenen on 9076 5031 or Emmy Gavrilidis on 9076 6913 or visit www.maprc.org.au. For more about the study, see Monash story.